Literature DB >> 3116749

Serotyping of Haemophilus pleuropneumoniae in the Netherlands: with emphasis on heterogeneity within serotype 1 and (proposed) serotype 9.

E M Kamp1, J K Popma, L A Van Leengoed.   

Abstract

Four hundred and forty-three Dutch field isolates of Haemophilus pleuropneumoniae were serotyped by rapid slide agglutination (RSA) using specific antisera against serotypes 1 to 5 and against the recently proposed types 6 to 9. The predominant serotypes were 9 (49%) and 2 (32%). Serotypes 1, 3, 5, 7 and 8 were isolated in small numbers: together they accounted for 3% of the total. Five percent of the isolates were not typable either due to autoagglutination or because they were not agglutinated by any of the available antisera. The remaining 49 strains (11%) agglutinated in more than one antiserum and could therefore not be properly classified. Forty-four of these 49 strains agglutinated in both anti type 1 and anti type 9 serum. Antigenic relationships between serotype 1, serotype 9 and isolates reacting with both antisera were studied using immunodiffusion and RSA with adsorbed sera. Serotype 9 strains appeared not to be a homogenous group. Isolates agglutinating exclusively in anti type 9 serum can be divided into two groups: one closely related and another hardly related to serotype 1. Serotype 9 reference strain 13261 belongs to the latter. Type 1 + 9 strains have antigens in common with serotypes 1 and 9, but they also have their own specific antigenic material. Such strains are proposed as a new serotype 10.

Entities:  

Mesh:

Year:  1987        PMID: 3116749     DOI: 10.1016/0378-1135(87)90087-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  17 in total

1.  Serotype-related differences in production and type of heat-labile hemolysin and heat-labile cytotoxin of Actinobacillus (Haemophilus) pleuropneumoniae.

Authors:  E M Kamp; L A van Leengoed
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

2.  Cross-reactions between Actinobacillus (Haemophilus) pleuropneumoniae strains of serotypes 1 and 9.

Authors:  K R Mittal
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Multiplex PCR that can distinguish between immunologically cross- reactive serovar 3, 6, and 8 Actinobacillus pleuropneumoniae strains.

Authors:  L Zhou; S C P Jones; Ø Angen; J T Bossé; J H E Nash; J Frey; R Zhou; H C Chen; J S Kroll; A N Rycroft; P R Langford
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

4.  Cross-reactivity and antigenic heterogeneity among Actinobacillus pleuropneumoniae strains of serotypes 4 and 7.

Authors:  K R Mittal; S Bourdon
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

5.  Serological characterization of Actinobacillus pleuropneumoniae biotype 1 strains antigenically related to both serotypes 2 and 7.

Authors:  R Nielsen; L O Andresen; T Plambeck
Journal:  Acta Vet Scand       Date:  1996       Impact factor: 1.695

6.  Hemolysin patterns of Actinobacillus pleuropneumoniae.

Authors:  J Frey; J Nicolet
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Molecular cloning and expression of ptxA, the gene encoding the 120-kilodalton cytotoxin of Actinobacillus pleuropneumoniae serotype 2.

Authors:  J MacDonald; A N Rycroft
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

8.  Efficacy of a cell extract from Actinobacillus (Haemophilus) pleuropneumoniae serotype 1 against disease in swine.

Authors:  P J Fedorka-Cray; M J Huether; D L Stine; G A Anderson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

9.  Characterization of the lipopolysaccharide O antigens of Actinobacillus pleuropneumoniae serotypes 9 and 11: antigenic relationships among serotypes 9, 11, and 1.

Authors:  L M Beynon; D W Griffith; J C Richards; M B Perry
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

10.  Identification of hemolytic and cytotoxic proteins of Actinobacillus pleuropneumoniae by use of monoclonal antibodies.

Authors:  E M Kamp; J K Popma; J Anakotta; M A Smits
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.